07/10/2026
Cancer Cases Are Expected to Nearly Double by 2050.
The latest report from the World Health Organization (WHO) delivers a powerful reminder that we need to rethink how we approach multicancer risk early detection.
By 2050, the number of new cancer cases worldwide is projected to increase from 20.6 million to nearly 35 million annually. Every day, cancer claims more than 26,000 lives, making it the second leading cause of death globally.
The WHO calls for urgent action, emphasizing the importance of prevention, earlier detection, and improving access to cancer care.
At OneTest, we believe early cancer risk detection should also be more accessible, more convenient, and more affordable.
Instead of focusing on a single type of cancer, OneTest for Cancer is designed to assess the risk of 20+ cancers through a single blood test. With at-home blood collection, FDA-approved biomarkers, and AI-powered analysis, our goal is to make proactive cancer risk assessment easier to access and practical to repeat over time.
As the global burden of cancer continues to grow, innovative approaches to early detection will become increasingly important in helping more people take a proactive role in their health.
The future of cancer care starts with detecting risk earlier.
Read the WHO report: https://www.iarc.who.int/news-events/who-calls-for-urgent-action-as-new-cancer-cases-are-projected-to-nearly-double-by-2050/